Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Elocalcitol - Adge Pharmaceuticals

Next Previous
Drug Profile

Elocalcitol - Adge Pharmaceuticals

Alternative Names: RO-269228

Latest Information Update: 28 May 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Roche Palo Alto LLC
  • Developer Adge Pharmaceuticals
  • Class Dihydroxycholecalciferols; Small molecules; Urologics; Vitamin D analogues
  • Mechanism of Action Calcitriol receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Osteogenesis imperfecta; Rett syndrome
  • Discontinued Postmenopausal osteoporosis

Most Recent Events

  • 28 May 2026 No recent reports of development identified for preclinical development in Osteogenesis-imperfecta in USA (PO)
  • 28 May 2026 No recent reports of development identified for preclinical development in Rett syndrome in USA (PO)
  • 25 Apr 2022 Elocalcitol licensed to Cyan Bio in South Korea, Greater China, Japan, India and Southeast Asian countries for the treatment of Rett syndrome and osteogenesis imperfecta

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top